NASDAQ · Drug Manufacturers - General

Amgen Inc (AMGN)

$439.33 +1.87%

Add alert

74 Overbought Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$347.52+26.42%

Company profile

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. Focused on molecular biology and biochemistry, its goal is to provide a healthcare business based on recombinant DNA technology.

SectorHealthcare

IndustryDrug Manufacturers - General

Market cap$224.14B

P/E ratio25.73

EPS$16.10

Beta0.413

Dividend yield2.35%

52-week high$421.79

52-week low$264.02

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 72 LLY Lilly(Eli) & Company RSI 60 JNJ Johnson & Johnson RSI 62 BMY Bristol-Myers Squibb Company RSI 63 MRK Merck & Co Inc RSI 78 NVO Novo Nordisk RSI 50 ABBV Abbvie Inc RSI 64 GILD Gilead Sciences Inc RSI 67 GSK GSK Plc RSI 56 OGN Organon & Company RSI 75

Free forever

RSI alerts for AMGN

Get an email the moment Amgen Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 6:46 AM EDT